![]() |
Volumn 45, Issue 2, 2001, Pages 139-145
|
Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders
|
Author keywords
Anticonvulsants; Bipolar disorder; Gabapentin; Life event; Mood stabilizers
|
Indexed keywords
ANTICONVULSIVE AGENT;
BENZODIAZEPINE;
CARBAMAZEPINE;
CLOZAPINE;
GABAPENTIN;
HALOPERIDOL;
LAMOTRIGINE;
NEUROLEPTIC AGENT;
PAROXETINE;
PHENOBARBITAL;
RISPERIDONE;
VIGABATRIN;
ACUTE PANCREATITIS;
ADULT;
ANXIETY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
FEMALE;
HUMAN;
HYPONATREMIA;
INTELLECTUAL IMPAIRMENT;
LEUKOPENIA;
LIFE EVENT;
MALE;
MANIC DEPRESSIVE PSYCHOSIS;
MENTAL DISEASE;
REHABILITATION;
SIDE EFFECT;
STANDARDIZATION;
SYMPTOM;
SYMPTOMATOLOGY;
ACETIC ACIDS;
ADULT;
AMINES;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
COMORBIDITY;
CYCLOHEXANECARBOXYLIC ACIDS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
MALE;
MENTAL RETARDATION;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOTROPIC DRUGS;
|
EID: 0035053060
PISSN: 09642633
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2788.2001.00330.x Document Type: Article |
Times cited : (14)
|
References (30)
|